Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.03 (-11.87%)
Close on Nov 13, 2026Market cap $3.86MP/E –Yield –
Traws Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Traws Pharma's enterprise value was -$1.20M on Nov 11, 2026, against $12.83M a year earlier. Over the last 5 years it ranged from -$31.49M to $21.46M, with a median of -$8.73M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.20M | -173.2% |
| 2025 | Dec 31, 2025 | $1.64M | -92.4% |
| 2024 | Dec 31, 2024 | $21.46M | – |
| 2023 | Dec 29, 2023 | -$9.58M | – |
| 2022 | Dec 30, 2022 | -$29.01M | – |
| 2021 | Dec 31, 2021 | -$6.11M | -109.8% |
| 2020 | Dec 31, 2020 | $62.54M | – |
| 2019 | Dec 31, 2019 | -$1.68M | – |
| 2018 | Dec 31, 2018 | -$10.41M | -230.1% |
| 2017 | Dec 29, 2017 | $8.00M | – |
| 2016 | Dec 30, 2016 | -$9.60M | -802.4% |
| 2015 | Dec 31, 2015 | $1.37M | -95.4% |
| 2014 | Dec 31, 2014 | $29.48M | -82.6% |
| 2013 | Dec 31, 2013 | $169.42M | – |
See a number that looks wrong?